<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
------
Endosonics Corp.
----------------------------------
(Name of Issuer)
COMMON
----------------------------------
(Title of Class of Securities)
29264K105
----------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement. /X/ (A
fee is not required only if the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
(Continued on following page(s))
<PAGE>
CUSIP No. 29264K105 13G
---------
- -------------------------------------------------------------------------------
1 Names of Reporting Person. S.S. or I.R.S. Identification No. of Above
Person
WELLS FARGO BANK, N.A.
- -------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member (a) / /
of a Group* (b) / /
- -------------------------------------------------------------------------------
3 SEC Use Only
- -------------------------------------------------------------------------------
4 Citizenship or Place of Organization
U.S.A.
- -------------------------------------------------------------------------------
Number of Shares 5 Sole Voting
Beneficially Power
597,800
Owned by --------------------------------------------------
Each Reporting 6 Shared Voting
Person With Power
9,000
--------------------------------------------------
7 Sole Dispositive
Power
619,589
--------------------------------------------------
8 Shared Dispositive
Power
7,500
- -------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
627,089
- -------------------------------------------------------------------------------
10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
5.0%
- -------------------------------------------------------------------------------
12 Type of Reporting Person*
Bank
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
- -------------------------------------------------------------------------------
Item 1(a). NAME OF ISSUER:
Endosonics Corp.
Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
6616 Owens Drive
Pleasanton, CA 94588
Item 2(c). NAME OF PERSON FILING:
Wells Fargo Bank, National Association
Item 2(b). ADDRESS OR PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
464 California Street
San Francisco, California 94163
Item 2(c). CITIZENSHIP:
U.S.A.
Item 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock
Item 2(e). CUSIP NUMBER:
29264K105
Item 3. THE PERSONS FILING THIS SCHEDULE, PURSUANT TO PARAGRAPH 240.13d-
1(b) ARE A:
(b) (X) Bank as defined in Section 3(a)(6) of the Act.
Item 4. OWNERSHIP:
See items 5-11 of cover page.
Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
Not applicable.
<PAGE>
Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
The shares reported are held in trust accounts for the economic
benefit of the beneficiaries of those accounts.
Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY:
Not applicable.
Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
Not applicable.
Item 9. NOTICE OF DISSOLUTION OF GROUP:
Not applicable.
Item 10. CERTIFICATION:
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose
of and do not have the effect of changing or influencing the
control of the issuer of such securities and were not acquired in
connection with or as a participant in any transaction having
such purposes or effect.
SIGNATURE:
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
2-6-96 By: /s/ Guy Rounsaville, Jr.
- -------------------- -------------------------
Date GUY ROUNSAVILLE, JR.
Executive Vice President,
Chief Counsel and Secretary
WELLS FARGO BANK, N.A.
2-6-96 By: /s/ Guy Rounsaville, Jr.
- -------------------- -------------------------
Date GUY ROUNSAVILLE, JR.
Executive Vice President,
Chief Counsel and Secretary
WELLS FARGO AND COMPANY
